Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mono-oxygenase activities in female rats

W. A. Al-Turk, S. J. Stohs, E. B. Roche

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of acutely and chronically administered estrone (E1), estradiol (E2) and estriol (E3) on microsomal aryl and hydrocarbon hydroxylase (AHH) activity, 7-ethoxycoumarin O-de-ethylase (ECD) activity, and cytochrome P-450 content in rat liver, lung and intestinal mucosa were compared. Forty-day-old Sprague-Dawley female rats were given 1.0 mg of E1, E2, or E3 per kg ip, twice daily for 2 days in acute studies, and once daily for 7 days in chronic studies. Acute treatment with E1, E2, and E3 resulted in significant increases in hepatic and intestinal AHH activities, and hepatic cytochrome P-450 content. Acute treatment of female rats with the three estrogens had no effect on hepatic, pulmonary, and intestinal ECD activities. After acute treatment, the AHH activity of lung microsomes increased approximately 2-fold with E3, remained unchanged with E1, and exhibited a decrease with E2. Acute treatment with E1, E2 and E3 produced no changes in pulmonary ECD activity. Chronic treatment of the animals with E3 resulted in a significant increase in intestinal AHH activity, but no changes in the AHH of ECD activities of lungs or liver. Chronic treatment with E1 and E2 produced increased activities of liver and intestinal AHH and ECD, and increased hepatic cytochrome P-450 content. Both chronic E1 and E2 significantly decreased lung microsomal AHH and ECD activities. A time-course study with E3 demonstrated that maximum activity of AHH in lungs and liver occurred after 2 days of treatment and decreased thereafter, returning to normal by day 3. These data indicate that in the female rat the inducibility of AHH and ECD activities are organ-specific and depend upon the estrogen administered as well as the duration of steroid treatment. The difference observed may be explained on the basis of estrogen receptors.

Original languageEnglish (US)
Pages (from-to)143-146
Number of pages4
JournalDrug Metabolism and Disposition
Volume8
Issue number3
StatePublished - Jan 1 1980

Fingerprint

Aryl Hydrocarbon Hydroxylases
Oxygenases
Estriol
Estrone
Mixed Function Oxygenases
Rats
Estradiol
Lung
Liver
Cytochrome P-450 Enzyme System
Estrogens
7-Alkoxycoumarin O-Dealkylase
Time and motion study
Intestinal Mucosa
Microsomes
Estrogen Receptors
Sprague Dawley Rats
Steroids
Animals

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mono-oxygenase activities in female rats. / Al-Turk, W. A.; Stohs, S. J.; Roche, E. B.

In: Drug Metabolism and Disposition, Vol. 8, No. 3, 01.01.1980, p. 143-146.

Research output: Contribution to journalArticle

@article{62994c09e6374c50ac9a95313a707b80,
title = "Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mono-oxygenase activities in female rats",
abstract = "The effects of acutely and chronically administered estrone (E1), estradiol (E2) and estriol (E3) on microsomal aryl and hydrocarbon hydroxylase (AHH) activity, 7-ethoxycoumarin O-de-ethylase (ECD) activity, and cytochrome P-450 content in rat liver, lung and intestinal mucosa were compared. Forty-day-old Sprague-Dawley female rats were given 1.0 mg of E1, E2, or E3 per kg ip, twice daily for 2 days in acute studies, and once daily for 7 days in chronic studies. Acute treatment with E1, E2, and E3 resulted in significant increases in hepatic and intestinal AHH activities, and hepatic cytochrome P-450 content. Acute treatment of female rats with the three estrogens had no effect on hepatic, pulmonary, and intestinal ECD activities. After acute treatment, the AHH activity of lung microsomes increased approximately 2-fold with E3, remained unchanged with E1, and exhibited a decrease with E2. Acute treatment with E1, E2 and E3 produced no changes in pulmonary ECD activity. Chronic treatment of the animals with E3 resulted in a significant increase in intestinal AHH activity, but no changes in the AHH of ECD activities of lungs or liver. Chronic treatment with E1 and E2 produced increased activities of liver and intestinal AHH and ECD, and increased hepatic cytochrome P-450 content. Both chronic E1 and E2 significantly decreased lung microsomal AHH and ECD activities. A time-course study with E3 demonstrated that maximum activity of AHH in lungs and liver occurred after 2 days of treatment and decreased thereafter, returning to normal by day 3. These data indicate that in the female rat the inducibility of AHH and ECD activities are organ-specific and depend upon the estrogen administered as well as the duration of steroid treatment. The difference observed may be explained on the basis of estrogen receptors.",
author = "Al-Turk, {W. A.} and Stohs, {S. J.} and Roche, {E. B.}",
year = "1980",
month = "1",
day = "1",
language = "English (US)",
volume = "8",
pages = "143--146",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mono-oxygenase activities in female rats

AU - Al-Turk, W. A.

AU - Stohs, S. J.

AU - Roche, E. B.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - The effects of acutely and chronically administered estrone (E1), estradiol (E2) and estriol (E3) on microsomal aryl and hydrocarbon hydroxylase (AHH) activity, 7-ethoxycoumarin O-de-ethylase (ECD) activity, and cytochrome P-450 content in rat liver, lung and intestinal mucosa were compared. Forty-day-old Sprague-Dawley female rats were given 1.0 mg of E1, E2, or E3 per kg ip, twice daily for 2 days in acute studies, and once daily for 7 days in chronic studies. Acute treatment with E1, E2, and E3 resulted in significant increases in hepatic and intestinal AHH activities, and hepatic cytochrome P-450 content. Acute treatment of female rats with the three estrogens had no effect on hepatic, pulmonary, and intestinal ECD activities. After acute treatment, the AHH activity of lung microsomes increased approximately 2-fold with E3, remained unchanged with E1, and exhibited a decrease with E2. Acute treatment with E1, E2 and E3 produced no changes in pulmonary ECD activity. Chronic treatment of the animals with E3 resulted in a significant increase in intestinal AHH activity, but no changes in the AHH of ECD activities of lungs or liver. Chronic treatment with E1 and E2 produced increased activities of liver and intestinal AHH and ECD, and increased hepatic cytochrome P-450 content. Both chronic E1 and E2 significantly decreased lung microsomal AHH and ECD activities. A time-course study with E3 demonstrated that maximum activity of AHH in lungs and liver occurred after 2 days of treatment and decreased thereafter, returning to normal by day 3. These data indicate that in the female rat the inducibility of AHH and ECD activities are organ-specific and depend upon the estrogen administered as well as the duration of steroid treatment. The difference observed may be explained on the basis of estrogen receptors.

AB - The effects of acutely and chronically administered estrone (E1), estradiol (E2) and estriol (E3) on microsomal aryl and hydrocarbon hydroxylase (AHH) activity, 7-ethoxycoumarin O-de-ethylase (ECD) activity, and cytochrome P-450 content in rat liver, lung and intestinal mucosa were compared. Forty-day-old Sprague-Dawley female rats were given 1.0 mg of E1, E2, or E3 per kg ip, twice daily for 2 days in acute studies, and once daily for 7 days in chronic studies. Acute treatment with E1, E2, and E3 resulted in significant increases in hepatic and intestinal AHH activities, and hepatic cytochrome P-450 content. Acute treatment of female rats with the three estrogens had no effect on hepatic, pulmonary, and intestinal ECD activities. After acute treatment, the AHH activity of lung microsomes increased approximately 2-fold with E3, remained unchanged with E1, and exhibited a decrease with E2. Acute treatment with E1, E2 and E3 produced no changes in pulmonary ECD activity. Chronic treatment of the animals with E3 resulted in a significant increase in intestinal AHH activity, but no changes in the AHH of ECD activities of lungs or liver. Chronic treatment with E1 and E2 produced increased activities of liver and intestinal AHH and ECD, and increased hepatic cytochrome P-450 content. Both chronic E1 and E2 significantly decreased lung microsomal AHH and ECD activities. A time-course study with E3 demonstrated that maximum activity of AHH in lungs and liver occurred after 2 days of treatment and decreased thereafter, returning to normal by day 3. These data indicate that in the female rat the inducibility of AHH and ECD activities are organ-specific and depend upon the estrogen administered as well as the duration of steroid treatment. The difference observed may be explained on the basis of estrogen receptors.

UR - http://www.scopus.com/inward/record.url?scp=0018869733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018869733&partnerID=8YFLogxK

M3 - Article

C2 - 6104576

AN - SCOPUS:0018869733

VL - 8

SP - 143

EP - 146

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 3

ER -